Mymd Pharmaceuticals Stock Net Income
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
MyMD Pharmaceuticals fundamentals help investors to digest information that contributes to MyMD Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of MyMD Stock. The fundamental analysis module provides a way to measure MyMD Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MyMD Pharmaceuticals stock.
MyMD |
MyMD Pharmaceuticals Company Net Income Analysis
MyMD Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current MyMD Pharmaceuticals Net Income | (4 M) |
Most of MyMD Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MyMD Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, MyMD Pharmaceuticals reported net income of (4 Million). This is 101.17% lower than that of the Biotechnology sector and 105.71% lower than that of the Health Care industry. The net income for all United States stocks is 100.7% higher than that of the company.
MyMD Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MyMD Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics of similar companies.MyMD Pharmaceuticals is currently under evaluation in net income category among its peers.
MyMD Fundamentals
| Return On Equity | -1.01 | |||
| Return On Asset | -0.5 | |||
| Current Valuation | 2.99 M | |||
| Shares Outstanding | 2.37 M | |||
| Shares Owned By Insiders | 6.61 % | |||
| Shares Owned By Institutions | 6.62 % | |||
| Number Of Shares Shorted | 263.62 K | |||
| Price To Book | 0.46 X | |||
| EBITDA | (17.12 M) | |||
| Net Income | (4 M) | |||
| Cash And Equivalents | 5.62 M | |||
| Cash Per Share | 0.15 X | |||
| Total Debt | 48.87 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.41 X | |||
| Book Value Per Share | 4.54 X | |||
| Cash Flow From Operations | (12.98 M) | |||
| Short Ratio | 2.71 X | |||
| Earnings Per Share | (9.27) X | |||
| Beta | 2.69 | |||
| Market Capitalization | 4.31 M | |||
| Total Asset | 17.86 M | |||
| Retained Earnings | (101.98 M) | |||
| Working Capital | 828.25 K | |||
| Net Asset | 17.86 M |
About MyMD Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MyMD Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in MyMD Stock
If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |